Analysis Of Cancer Risks In Populations Near Nuclear Facilities

In the late 1980s, the National Cancer Institute initiated an investigation of cancer risks in populations near 52 commercial nuclear power plants and 10 Department of Energy nuclear facilities (including research and nuclear weapons production facilities and one reprocessing plant) in the United States. The results of the NCI investigation were used a primary resource for communicating with the public about the cancer risks near the nuclear facilities. However, this study is now over 20 years old. The U.S. Nuclear Regulatory Commission requested that the National Academy of Sciences provide an updated assessment of cancer risks in populations near USNRC-licensed nuclear facilities that utilize or process uranium for the production of electricity. Analysis of Cancer Risks in Populations near Nuclear Facilities: Phase 1 focuses on identifying scientifically sound approaches for carrying out an assessment of cancer risks associated with living near a nuclear facility, judgments about the strengths and weaknesses of various statistical power, ability to assess potential confounding factors, possible biases, and required effort. The results from this Phase 1 study will be used to inform the design of cancer risk assessment, which will be carried out in Phase 2. This report is beneficial for the general public, communities near nuclear facilities, stakeholders, healthcare providers, policy makers, state and local officials, community leaders, and the media.

Analysis of Cancer Risks in Populations near Nuclear Facilities is a pilot study requested by the United States Nuclear Regulatory Commission (USNRC) to assess the risk of cancer near nuclear facilities in the United States. This effort is being carried out in two phases. The Phase 1 study recommended two study designs appropriate for assessing cancer risks near nuclear facilities. It also recommended a pilot study of seven nuclear facilities to assess the technical feasibility of the recommended study designs. The Phase 2 study is the assessment of cancer risks. The pilot, which is part of the Phase 2 study, is being carried out in two steps: pilot planning and pilot execution. The pilot planning (current step) aims to plan for the pilot study. The pilot execution (next step) aims to carry out the pilot study and evaluate the technical feasibility of implementing the two study designs recommended in the Phase 1 study. If implementation of the study designs is feasible, the methods developed and tested in the pilot study could be used to conduct a nationwide study. Analysis of Cancer Risks in Populations Near Nuclear Facilities: Phase 2 Pilot Planning provides advice to the National Academy of Sciences in performing a number of tasks related to the planning for a pilot epidemiological study, such as identifying the processes for selecting qualified individuals and/or organizations to perform epidemiological and dosimetric tasks and initiating effluent release and meteorological data collection in preparation for estimating doses to the people who live near the pilot nuclear facilities. This report brief report serves as a public record of the committee's advice to the National Academy of Sciences on general methodological considerations involved in carrying out the pilot study.

This book is the seventh in a series of titles from the National Research Council that addresses the effects of exposure to low dose LET (Linear Energy Transfer) ionizing radiation and human health. Updating information previously presented in the 1990 publication, Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V, this book draws upon new data in both epidemiologic and experimental research. Ionizing radiation arises from both natural and man-made sources and at very high doses can produce damaging effects in human tissue that can be evident within days after exposure. However, it is the low-dose exposures that are the focus of this book. So-called “late” effects, such as cancer, are produced many years after the initial exposure. This book is among the first of its kind to include detailed risk estimates for cancer incidence in addition to cancer mortality. BEIR VII offers a full review of the available biological, biophysical, and epidemiological literature since the last BEIR report on the subject and develops the most up-to-date and comprehensive risk estimates for cancer and other health effects from exposure to low-level ionizing radiation.

Though overall cancer incidence and mortality have continued to decline in recent years, cancer continues to devastate the lives of far too many Americans. In 2009 alone, 1.5 million American men, women, and children were diagnosed with cancer, and 562,000 died from the disease. There is a growing body of evidence linking environmental exposures to cancer. The Pres. Cancer Panel dedicated its 2008¿2009 activities to examining the impact of environmental factors on cancer risk. The Panel considered industrial, occupational, and agricultural exposures as well as exposures related to medical practice, military activities, modern lifestyles, and natural sources. This report presents the Panel¿s recommend. to mitigate or eliminate these barriers. Illus.

In 1997, after more than a decade of research, the National Cancer Institute (NCI) released a report which provided their assessment of radiation exposures that Americans may have received from radioactive iodine released from the atomic bomb tests conducted in Nevada during the 1950s and early 1960s. This book provides an evaluation of the soundness of the methodology used by the NCI study to estimate: Past radiation doses. Possible health consequences of exposure to iodine-131. Implications for clinical practice. Possible public health strategiesâ€"such as systematic screening for thyroid cancerâ€"to respond to the exposures. In addition, the book provides an evaluation of the NCI estimates of the number of thyroid cancers that might result from the nuclear testing program and provides guidance on approaches the U.S. government might use to communicate with the public about Iodine-131 exposures and health risks.